Nuzenio

Ampligen Dosing

Ampligen Dosing news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 5 publisher sources 100/100 entity strength

Latest news

AIM ImmunoTech Q2 loss widens to $3.8M, EPS misses estimates - scanx.tradescanx.trade · Mon, 10 Aug 2026 13:48:48 GMT AIM ImmunoTech Reports Completion of Phase 2 Ampligen Dosing in Metastatic Pancreatic Cancer Trial, Advances Phase 3 Planning - Quiver QuantitativeQuiver Quantitative · Mon, 10 Aug 2026 12:47:00 GMT AIM Completes Pancreatic Cancer Study Dosing; Phase 3 Planned - Stock TitanStock Titan · Mon, 10 Aug 2026 12:36:00 GMT AIM Stock Soars 42% As Pancreatic Cancer Trial Hits Key Enrollment Milestone Before Schedule — CEO Sees 'Significant Value-Inflection Period' Ahead - StocktwitsStocktwits · Sat, 08 Aug 2026 04:12:05 GMT AIM ImmunoTech Ahead of Schedule on ‘Last Dose’ DURIPANC Critical Clinical Inflection Point - GlobeNewswireGlobeNewswire · Mon, 03 Aug 2026 12:33:00 GMT

Timeline

Mon, 10 Aug 2026 13:48:48 GMTAIM ImmunoTech Q2 loss widens to $3.8M, EPS misses estimates - scanx.trade

Mon, 10 Aug 2026 12:47:00 GMTAIM ImmunoTech Reports Completion of Phase 2 Ampligen Dosing in Metastatic Pancreatic Cancer Trial, Advances Phase 3 Planning - Quiver Quantitative

Mon, 10 Aug 2026 12:36:00 GMTAIM Completes Pancreatic Cancer Study Dosing; Phase 3 Planned - Stock Titan

Sat, 08 Aug 2026 04:12:05 GMTAIM Stock Soars 42% As Pancreatic Cancer Trial Hits Key Enrollment Milestone Before Schedule — CEO Sees 'Significant Value-Inflection Period' Ahead - Stocktwits

Mon, 03 Aug 2026 12:33:00 GMTAIM ImmunoTech Ahead of Schedule on ‘Last Dose’ DURIPANC Critical Clinical Inflection Point - GlobeNewswire

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Phase4 live mentions Schedule4 live mentions AIM ImmunoTech2 live mentions EPS2 live mentions Metastatic Pancreatic Cancer2 live mentions Trial2 live mentions Advances Phase2 live mentions As Pancreatic Cancer2 live mentions Trial Hits Key2 live mentions Enrollment Milestone Before2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ampligen Dosing.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.